Efficacy of Cetuximab in the Treatment of Ménétrier’s Disease
- 25 November 2009
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 1 (8) , 8ra18
Abstract
An antibody to the epidermal growth factor receptor successfully treats nine patients with a disease in which the lining of the stomach abnormally proliferates.Keywords
This publication has 54 references indexed in Scilit:
- IDPicker 2.0: Improved Protein Assembly with High Discrimination Peptide Identification FilteringJournal of Proteome Research, 2009
- Evaluation of Strong Cation Exchange versus Isoelectric Focusing of Peptides for Multidimensional Liquid Chromatography-Tandem Mass SpectrometryJournal of Proteome Research, 2008
- Cetuximab for the Treatment of Colorectal CancerNew England Journal of Medicine, 2007
- Proteomic Parsimony through Bipartite Graph Analysis Improves Accuracy and TransparencyJournal of Proteome Research, 2007
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Potentiation of Oxyntic Atrophy–Induced Gastric Metaplasia in Amphiregulin-Deficient MiceGastroenterology, 2007
- Primary Squamous Cell Carcinoma of the Stomach That Developed with Menetrier's DiseaseDigestive Diseases and Sciences, 2007
- Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomachJournal of Clinical Investigation, 2007
- Reversible drug–induced oxyntic atrophy in ratsGastroenterology, 2000
- Hypertrophic Gastropathy Symptoms Responsive to Prednisone A Case Report and a Review of the LiteratureJournal of Clinical Gastroenterology, 1991